Sherbrooke Park Advisers LLC Sutro Biopharma, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $313 Billion
- Q4 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 33,640 shares of STRO stock, worth $43,059. This represents 0.02% of its overall portfolio holdings.
Number of Shares
33,640
Previous 128,850
73.89%
Holding current value
$43,059
Previous $446 Million
86.12%
% of portfolio
0.02%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding STRO
# of Institutions
128Shares Held
59.9MCall Options Held
203KPut Options Held
33.6K-
Suvretta Capital Management, LLC New York, NY7.46MShares$9.55 Million0.57% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$8.85 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.21MShares$5.39 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.64MShares$4.66 Million0.42% of portfolio
-
Vestal Point Capital, LP New York, NY2.57MShares$3.29 Million0.28% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $66.8M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...